Vol.
36
No.
38
October 22, 2010Oct 22, 2010

IOM Review Of Duke Genomics Trials To Focus On Validation, Scientific Criteria

NCI Sends A Second Letter To Groups About Carboplatin

Agency Asks GnRH Sponsors To Add Warnings On Labels

NCI Awards STRAP Grant Of $2 Million To MSKCC

Beth Israel Suspends Enrollment In Trials Following An Audit

NCCN Guidelines Retain Avastin For Breast Cancer

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

“Dollars For Docs” Database Of Pharma Payments Posted By News Organization

Login